A problem combination?Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge Share XA problem combination?https://pharmaphorum.com/views-and-analysis/a-problem-combination/
When science and biology combine – the outlook for ADCs in cancer drug developmentAntibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents. Although just Share XWhen science and biology combine – the outlook for ADCs in cancer drug developmenthttps://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/
